GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,007,870 | -15.0% | 2,316,372 | +1.9% | 0.38% | -12.0% |
| Q2 2023 | $135,345,435 | +28.2% | 2,273,185 | +22.0% | 0.43% | +17.9% |
| Q1 2023 | $105,537,992 | -38.7% | 1,863,312 | -19.6% | 0.37% | -44.2% |
| Q4 2022 | $172,141,892 | +63.5% | 2,317,785 | +31.2% | 0.66% | +58.4% |
| Q3 2022 | $105,276,000 | +8.1% | 1,767,258 | +1.9% | 0.42% | +15.2% |
| Q2 2022 | $97,391,000 | +262.1% | 1,734,795 | +375.9% | 0.36% | +351.2% |
| Q1 2022 | $26,895,000 | +17.3% | 364,524 | +14.7% | 0.08% | +29.0% |
| Q4 2021 | $22,937,000 | +79.2% | 317,684 | +90.2% | 0.06% | +72.2% |
| Q3 2021 | $12,801,000 | +0.2% | 167,067 | +1.4% | 0.04% | -10.0% |
| Q2 2021 | $12,771,000 | +32.7% | 164,719 | +5.6% | 0.04% | +29.0% |
| Q1 2021 | $9,622,000 | +3703.2% | 156,022 | +3014.2% | 0.03% | +3000.0% |
| Q2 2018 | $253,000 | – | 5,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |